Bind Biosciences raises $16 million

January 22, 2008 | Analyst Insight

Bind Biosciences recently closed a $16 million Series B funding round, with investors including Polaris Venture Partners, Flagship Ventures, ARCH Ventures, and NanoDimension. Bind was founded in 2006 by Robert...

Related companies	NanoDimension, ARCH Venture Partners, Polaris Venture Partners, Harvard Medical School, Carigent Therapeutics, Bind Biosciences, Flagship Ventures, Brigham and Women's Hospital

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Interested in Learning More?

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978